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Radical antegrade modular pancreatosplenectomy (RAMPS) is regarded as a rea-
sonable approach for margin-negative and systemic lymph node clearance in left-
sided pancreatic cancer. We present a patient with more than 5 years disease-free 
survival after robotic anterior RAMPS for pancreatic ductal adenocarcinoma in the 
body of the pancreas. The distal part of pancreas, soft tissue around the celiac 
trunk, and the origin of splenic vessels was dissected with the underlying fascia 
between the pancreas and adrenal gland. Resected specimen was removed through 
small vertical abdominal incision. Robot working time was about 8 hours, and 
blood loss was about 700 mL without blood transfusion. He returned to an oral 
diet on the postoperative first day and recovered without any clinically relevant 
complications. There was no lymph node metastasis, perineural or lymphovascular 
invasion. Both the pancreatic resection margin and the tangential posterior margin 
were free of carcinoma. The patient received only postoperative adjuvant radio-
therapy around the tumor bed. The patient has survived for more than 5 years 
without evidence of cancer recurrence. Minimally invasive radical left-sided pan-
createctomy with splenectomy may be oncologically feasible in well-selected pan-
creatic cancer.
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INTRODUCTION
In the last few decades, laparoscopic surgery has replaced conventional open sur-
gery in the treatment of most elective gastrointestinal diseases, even malignancies 
such as gastric and colorectal cancers, with sound oncologic outomes.1,2 In addi-
tion, robotic surgical systems have been developed as a means of overcoming the 
limitations of conventional laparoscopic surgery and enhancing its efficacy.3
However, it was only recent movement that minimally invasive approaches be-
gan to be used in the treatment of pancreatic cancer. Radical antegrade modular 
pancreatosplenectomy (RAMPS) is regarded as a reasonable approach for margin-
negative and systemic lymph node clearance in left-sided pancreatic cancer,4 and 
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Surgery
The complete procedure is described in a multimedia article 
published previously.7,8 In brief, surgery was performed with 
the patient placed in the supine position. After division of 
both the gastrocolic and gastrosplenic ligaments, the whole 
pancreas was exposed. Following the main outline of the 
original RAMPS, a complete window could be made via 
the avascular plane between the pancreatic neck and superi-
or mesenteric vein-portal vein-splenic vein (SMV-PV-SV) 
confluence. This facilitated dissection of the lymph nodes 
around the common hepatic artery. Division of the pancreas 
was performed by endo-GIA at the pancreatic neck portion. 
The left gastric vein with soft tissue around celiac trunk and 
common hepatic artery were dissected (Fig. 1C). The splen-
ic artery and vein were controlled  at the origin of the celiac 
trunk and t the junction of the SV and SMV, respectively. 
The robotic surgical system is thought to be helpful for these 
dissectional processes. The superior mesenteric artery and 
left renal vessels were not aggressively dissected. The distal 
part of the pancreas was dissected with soft tissue around the 
celiac trun and the fascia layer covering the adrenal gland 
and perinephric soft tissue in a right-to-left fashion. An endo-
pouch was introduced and surgical specimen was retrieved 
through a small vertical abdominal wound. The total opera-
recent literature has reported the long-term oncologic out-
comes of RAMPS.5 Based on our past experiences with dis-
tal pancreatosplenectomy (DPS) for pancreatic cancer,6 we 
have selectively applied minimally invasive modified anteri-
or RAMPS since 2007. In this report, we present a patient 
who underwent first robotic anterior RAMPS and survived 
for more than five years without cancer recurrence. 
CASE REPORT
　　
Patient
A 72 year-old man (hight-172 cm, weight-78 kg, body mass 
index-26.37) with a three-month history of weight loss of 5 
kg was admitted to the Department of Surgery in Severance 
Hospital, Seoul, Korea. On preoperative axial imaging, he 
had a suspicious mass-like lesion confined to the pancreas, 
which was suggestive of pancreatic cancer (Fig. 1A and B). 
The tumor seemed not to invade retroperitoneal space and 
it was apart from celiac axis. The patient’s CA 19-9 was el-
evated to 60 IU/mL. After careful consideration, a decision 
to perform minimally invasive pancreatectomy was made 
based on the concept of anterior RAMPS, and a robotic sur-
gical system was subsequently used. 
Fig. 1. Perioperative surgical outcomes. Low attenuated pancreatic tumor located to the pancreatic body (A) with obstructive distal pancreatic duct dilata-
tion (B) was noted on pre-operative radiologic images. The mass was confined to the pancreatic body with intact fascia layer between the pancreas and 
left adrenal gland. In addition, tumor was apart from celiac axis more than 2 cm. Therefore, it was possible to be removed safely by modified anterior 
RAMPS [note the dissection plane, white dotted line, (A)].  Robot-assisted anterior RAMPS was performed, and pathology examination revealed that the tu-
mor was a pancreatic ductal adenocarcinoma with pT3N0M0, stage IIA (C and D). Postoperative adjuvant radiotherapy was given (E). Postoperative CA 
19-9 declined and remained within the normal range (F). *Soft tissue around celiac axis. pP, proximal pancreas; dP, distal pancreas; SAO, the origin of the 
splenic artery; SV, the junction of splenic vein to superior mesenteric vein; RAMPS, radical antegrade modular pancreatosplenectomy.
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proach for left-sided pancreatic cancer. However, recent 
clinical study suggest the technical feasibility and sound 
short-term perioperative oncologic outcomes.7,8,12-14 Particu-
larly, Daoudai, et al.15 evaluated a total of 27 cases of robotic 
distal pancreatectomy for pancreatic ductal adenocarcinoma 
and showed excellent perioperative oncologic outcomes. It is 
true that current robot surgical system has unique character-
istics to compensate the limitation of conventional laparo-
scopic surgery. In this case, we could take great advantages 
of three dimensional stable operative field provided by ro-
botic surgical system and wrist-like movement of laparo-
scopic instrument in dissection of soft tissue around celiac 
axis, effective vascular control at the origin of the splenic ar-
tery/vein, and making window between pancreas and SMV-
SV-PV confluence. However, it may be difficult to conclude 
that robot surgery will be superior in oncologic surgery for 
left sided pancreatic cancer, because 1) both robotic and 
laparoscopic approaches belong to the same category of 
minimally invasive surgery, therefore, the outcome may be 
similar. 2) Daoudai, et al.’s data should be criticized be-
cause of critical selection bias according to the time of sur-
gical approach.15 3) Moreover, conventional laparoscopic 
technique has been far advanced these days. Therefore, it is 
thought that the concept of minimally invasive radical pan-
createctomy using either robotic or laparoscopic approach 
seems more necessary rather than the view of which proce-
dure would be superior in this moment. In the near future, 
not only the technical feasibility but also oncologic concerns 
of minimally invasive radical pancreatectomy for left-sided 
pancreatectomy should be properly evaluated, based on 
long-term survival outcomes. 
In summary, we report a case of a patient selected for ro-
botic anterior RAMPS in the treatment of his left-sided pan-
creatic cancer. The patient may be the first long-term survi-
vor following robotic radical pancreatectomy for pancreatic 
ductal adenocarcinoma. Our findings underscore the ratio-
nale of Yonsei selection criteria for margin-negative anteri-
or RAMPS and may also suggest the oncologic feasibility 
of minimally invasive DPS in well-selected patients with 
pancreatic cancer. 
REFERENCES
1. Colon Cancer Laparoscopic or Open Resection Study Group, 
Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, et al. Sur-
vival after laparoscopic surgery versus open surgery for colon 
cancer: long-term outcome of a randomised clinical trial. Lancet 
tion time was eight hours and the intraoperative blood loss 
was 700 mL. 
Postoperative course
The patient recovered without any complications. He re-
turned to an oral diet on the first day and was discharged on 
the tenth day after operation. Pathologic examination re-
vealed a pancreatic ductal adenocarcinoma with extension 
into the peripancreatic soft tissue (pT3). Regional lymph 
node metastasis was not identified (pN0, 0/2). Both the pan-
creatic resection margin and the tangential posterior margin 
were free of carcinoma (Fig. 1D). No evidence of perineural 
and lymphovascular invasion was noted. The patient re-
ceived only postoperative adjuvant radiotherapy around the 
tumor bed (total 55.67 Gy/19 fractions, daily 2.93 Gy) (Fig. 
1E). His CA 19-9 remained within normal limits after sur-
gery (Fig. 1F), and the patient survived for more than five 
years without cancer recurrence.
DISCUSSION
Based on our surgical experiences,6 bloodless and margin-
negative resection is an important factor in treating left-sided 
pancreatic cancer. In general, the use of posterior RAMPS 
for pancreatic cancer that has invaded the retroperitoneal 
space is technically challenging. Thus, in applying minimal-
ly invasive approaches to left-sided pancreatic cancer, it 
would be the best to consider anterior RMAPS, in which the 
posterior dissection plane is placed anterior to the left adre-
nal gland. Potential tumor conditions that can be completely 
removed by minimally invasive (MI) anterior RAMPS in-
clude those (Yonsei-Criteria for-MI RMAPS): 1) confined 
to the pancreas, 2) with the intact fascia layer between the 
pancreas and left adrenal gland/kidney, and 3) more than 1 
to 2 cm from the celiac axis.7,8 In the past, several studies9-11 
have been published demonstrating the technical feasibility 
and clinical benefit of laparoscopic distal pancreatectomy 
over open distal pancreatectomy; however, most cases of 
pancreatic cancer (ductal adenocarcinoma) were included in 
these studies only incidentally. As a result, we cannot fully 
assess the surgical quality of these procedures in the treat-
ment of cancer based on the literature. In addition, the lack 
of information on tumor biologic characteristics, such as pT 
stage, pN stage, margin status, perineural/lymphovascular 
invasion, and survival outcomes, makes it difficult to deter-
mine the oncologic feasibility of minimally invasive ap-
Robotic RAMPS
Yonsei Med J   http://www.eymj.org   Volume 55   Number 1   January 2014 279
9. Taylor C, O’Rourke N, Nathanson L, Martin I, Hopkins G, Layani 
L, et al. Laparoscopic distal pancreatectomy: the Brisbane experi-
ence of forty-six cases. HPB (Oxford) 2008;10:38-42.
10. Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt MC, 
Merchant NB, et al. Left-sided pancreatectomy: a multicenter 
comparison of laparoscopic and open approaches. Ann Surg 
2008;248:438-46.
11. Jayaraman S, Gonen M, Brennan MF, D’Angelica MI, DeMatteo 
RP, Fong Y, et al. Laparoscopic distal pancreatectomy: evolution 
of a technique at a single institution. J Am Coll Surg 2010;211: 
503-9.
12. Fernández-Cruz L, Cosa R, Blanco L, Levi S, López-Boado MA, 
Navarro S. Curative laparoscopic resection for pancreatic neo-
plasms: a critical analysis from a single institution. J Gastrointest 
Surg 2007;11:1607-21.
13. Marangos IP, Buanes T, Røsok BI, Kazaryan AM, Rosseland AR, 
Grzyb K, et al. Laparoscopic resection of exocrine carcinoma in 
central and distal pancreas results in a high rate of radical resec-
tions and long postoperative survival. Surgery 2012;151:717-23.
14. Song KB, Kim SC, Park JB, Kim YH, Jung YS, Kim MH, et al. 
Single-center experience of laparoscopic left pancreatic resection 
in 359 consecutive patients: changing the surgical paradigm of left 
pancreatic resection. Surg Endosc 2011;25:3364-72.
15. Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, 
Bartlett DL, et al. Robot-assisted minimally invasive distal pan-
createctomy is superior to the laparoscopic technique. Ann Surg 
2013;257:128-32.
Oncol 2009;10:44-52. 
2. Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, 
Recher A, et al. Laparoscopic versus open subtotal gastrectomy 
for distal gastric cancer: five-year results of a randomized prospec-
tive trial. Ann Surg 2005;241:232-7.
3. Jacob BP, Gagner M. Robotics and general surgery. Surg Clin 
North Am 2003;83:1405-19.
4. Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade 
modular pancreatosplenectomy procedure for adenocarcinoma of 
the body and tail of the pancreas: ability to obtain negative tangen-
tial margins. J Am Coll Surg 2007;204:244-9. 
5. Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan DC, 
Strasberg SM. Long-term results of resection of adenocarcinoma 
of the body and tail of the pancreas using radical antegrade modu-
lar pancreatosplenectomy procedure. J Am Coll Surg 2012;214: 
46-52. 
6. Kang CM, Kim DH, Lee WJ. Ten years of experience with resec-
tion of left-sided pancreatic ductal adenocarcinoma: evolution and 
initial experience to a laparoscopic approach. Surg Endosc 2010; 
24:1533-41. 
7. Choi SH, Kang CM, Hwang HK, Lee WJ, Chi HS. Robotic ante-
rior RAMPS in well-selected left-sided pancreatic cancer. J Gas-
trointest Surg 2012;16:868-9.
8. Choi SH, Kang CM, Lee WJ, Chi HS. Multimedia article. Lapa-
roscopic modified anterior RAMPS in well-selected left-sided 
pancreatic cancer: technical feasibility and interim results. Surg 
Endosc 2011;25:2360-1. 
